Trial no.:
|
PACTR201505001139269 |
Date of Approval:
|
10/05/2015 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Pre-emptive paracetamol versus fentanyl on postadenotonsilectomy pain |
Official scientific title |
Pre-emptive paracetamol infusion versus fentanyl effects on postadenotonsilectomy pain in OSA patients. |
Brief summary describing the background
and objectives of the trial
|
OSA is common of all age in children, but mostly occurs between 2- 8 years age group, and its prevalence is equally between boys and girls. Hypertrophy of adenotonsillar tissue is the main factor in development of OSA during sleep in children. So, adenotonsillectomy is the main treatment for children OSA.
Posttonsilectomy pain, there is little published evidence to recommend a specific analgesic technique for T&A in the child with OSAS. Opioid, increased respiratory sensitivity, to respiratory depression during recovery period, including hypoxia.due to this potential respiratory problems , all children with history of OSA should receive an analgesic drugs that minimize these problems and pain control, postoperativelly. Paracetamol infusion is an alternative non opioid drug to relieve postoperative pain, its safety and pharmacokinetic properties have been established for children as young as 1 yr of age.
The present study was designed as randomized controlled trial to evaluate paracetamol as a preemptive analgesia in OSA undergoing adenotonsillectomy in compare with fentanyl as established analgesic (primary goal), detecting adverse events (secondary goal). |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
OSA |
Disease(s) or condition(s) being studied |
Obstructive Sleep Apnae, adenotonsillectomy,Oral Health,Respiratory,Surgery |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Supportive care |
Anticipated trial start date |
20/05/2015 |
Actual trial start date |
|
Anticipated date of last follow up |
20/11/2015 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
108 |
Actual target sample size (number of participants) |
120 |
Recruitment status |
Recruiting |
Publication URL |
|
|